AAALIXX

ETF / Mutual Fund
NASDAQ
JPMorgan Chase Financial Company LLC Autocallable Dual Directional Point to Point Barrier Note AAALI
Price Chart
Overview

About AAALIXX

Alliqua BioMedical Inc. merged with Adynxx, Inc. to form a NASDAQ-listed clinical-stage pharmaceutical company focusing on pain and inflammation treatments. The combined entity is headquartered in San Francisco under Adynxx's management team.

AUM
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Latest News for AAALIXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AAALIXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AAALIXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AAALIXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025